Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|May 5, 2012
Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancerYoshito Komatsu, Satoshi Yuki, Susumu Sogabe, et al.
Targeted Oncology|May 7, 2022
Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care ChemotherapyTakuro Mizukami, Masaki Takahashi, Yu Sunakawa, et al.
Cancers|November 14, 2023
Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)Takeshi Kajiwara, Tomohiro Nishina, Riu Yamashita, et al.
International Journal of Clinical Oncology|July 16, 2020
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective studyShintaro Nakano, Satoshi Yuki, Yasuyuki Kawamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Multicenter Phase I/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503/SCOOP Trial)Akihito Kawazoe, Yasutoshi Kuboki, Eiji Shinozaki, et al.
The Oncologist|March 18, 2022
Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201)Yasuyuki Kawamoto, Satoshi Yuki, Takashi Meguro, et al.
International Journal of Hematology|June 5, 2026
Influence of time, temperature, and mechanical agitation on whole-blood and plasma sample stability in coagulation testsMasato Matsuda, Masahiro Ieko, Yutaka Komiyama, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2011
Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancerKohei Shitara, Takashi Ura, Keitaro Matsuo, et al.
Cancers|March 13, 2024
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric CancerAkira Ueda, Satoshi Yuki, Takayuki Ando, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 16, 2015
Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patientsNozomu Fuse, Yasutoshi Kuboki, Takeshi Kuwata, et al.
Pageof 12